Veracyte, Inc.
DE ˙ DB ˙ US92337F1075
42,98 € ↑2,45 (6,04%)
2026-06-04
DEL PRIS
SecurityDE:12V / Veracyte, Inc.
InstitutionPacer Advisors, Inc.
Latest Disclosed Ownership8,199 shares
Latest Disclosed Value $ 264,090
Pacer Advisors, Inc. reports 20.24% decrease in ownership of 12V / Veracyte, Inc.

On May 6, 2026 - Pacer Advisors, Inc. filed a 13F-HR form disclosing ownership of 8,199 shares of Veracyte, Inc. (DE:12V) valued at $218,093 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on February 24, 2026 disclosing 10,280 shares of Veracyte, Inc.. This represents a change in shares of -20.24% during the quarter. The current value of the position is $352,393 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F Veracyte Common Stock - Domestic 92337F107 8,199 -2,081 -20.24 264 -38.89 0.0004
2026-02-24 2025-12-31 13F/A-1 Veracyte Common Stock - Domestic 92337F107 10,280 7,156 229.07 433 303.74 0.0011
2026-02-04 2025-12-31 13F Veracyte Common Stock - Domestic 92337F107 10,280 7,156 433 0.0006
2025-10-15 2025-09-30 13F Veracyte Common Stock - Domestic 92337F107 3,124 3,124 107 0.0003
2024-11-12 2024-09-30 13F Veracyte Common Stock - Domestic 92337F107 0 -626 -100.00 0 -100.00
2024-08-13 2024-06-30 13F Veracyte Common Stock - Domestic 92337F107 626 -811 -56.44 14 -58.06 0.0000
2024-05-10 2024-03-31 13F Veracyte Common Stock - Domestic 92337F107 1,437 1,437 32 0.0001
2021-07-21 2021-06-30 13F VERACYTE Common Stock 92337F107 0 -1,488 -100.00 0 -100.00
2021-04-05 2021-03-31 13F VERACYTE Common Stock 92337F107 1,488 -720 -32.61 80 -25.93 0.0014
2021-01-20 2020-12-31 13F VERACYTE Common Stock 92337F107 2,208 -172 -7.23 108 40.26 0.0020
2020-10-19 2020-09-30 13F VERACYTE Common Stock 92337F107 2,380 2,380 77 0.0016
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.